Literature DB >> 32039261

Cord blood transplantation for bone marrow failure syndromes: state of art.

Simona Pagliuca1, Annalisa Ruggeri2,3,4, Régis Peffault de Latour1.   

Abstract

Hematopoietic stem cell transplantation (HSCT) and immunosuppressive therapy (IST) represent the milestones of the treatment algorithm for idiopathic and inherited bone marrow failure (BMF) disorders. However, patients lacking a suitable donor or failing IST still have a poor prognosis. Cord blood transplantation (CBT) has extended the possibility of HSCT for many patients in case of the absence of an eligible donor, and although in the last years, this procedure is less used in several hematological diseases, it remains an option for the treatment of patients with BMF syndromes. Nevertheless, optimization of conditioning regimen and cord blood unit selection is warranted to reduce the risk of graft failure and transplant-related mortality. This review summarizes the state of art of CBT in the field of BMF diseases, focusing on historical and recent issues in idiopathic aplastic anemia and inherited disorders. 2019 Stem Cell Investigation. All rights reserved.

Entities:  

Keywords:  Cord blood transplantation (CBT); Fanconi anemia (FA); bone marrow failure (BMF); severe aplastic anemia (SAA)

Year:  2019        PMID： 32039261      PMCID： PMC6987328          DOI： 10.21037/sci.2019.10.04

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


  90 in total

1.  A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia.

Authors:  Yachiyo Kuwatsuka; Junya Kanda; Hirohito Yamazaki; Takehiko Mori; Koichi Miyamura; Shinichi Kako; Naoyuki Uchida; Kazuteru Ohashi; Yukiyasu Ozawa; Yoshiyuki Takahashi; Chiaki Kato; Koji Iwato; Ken Ishiyama; Hikaru Kobayashi; Tetsuya Eto; Kaoru Kahata; Jun Kato; Toshihiro Miyamoto; Koji Kato; Shinicihro Mori; Yoshiko Atsuta; Fumihiko Kimura; Yoshinobu Kanda
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-08       Impact factor: 5.742

2.  Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.

Authors:  T Peled; J Mandel; R N Goudsmid; C Landor; N Hasson; D Harati; M Austin; A Hasson; E Fibach; E J Shpall; A Nagler
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

3.  Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.

Authors:  M Bitan; R Or; M Y Shapira; M Aker; I B Resnick; A Ackerstein; S Samuel; S Elad; S Slavin
Journal:  Biol Blood Marrow Transplant       Date:  2006-07       Impact factor: 5.742

Review 4.  Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.

Authors:  Pasquale Barbaro; Aditi Vedi
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-08       Impact factor: 5.742

5.  Expansion of human cord blood hematopoietic stem cells for transplantation.

Authors:  Song Chou; Pat Chu; William Hwang; Harvey Lodish
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

6.  Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Simona Pagliuca; Régis Peffault de Latour; Fernanda Volt; Franco Locatelli; Marco Zecca; Jean-Hugues Dalle; Patrizia Comoli; Kim Vettenranta; Miguel Angel Diaz; Or Reuven; Yves Bertrand; Cristina Diaz de Heredia; Arnon Nagler; Ardeshir Ghavamzadeh; Sabina Sufliarska; Sarah Lawson; Chantal Kenzey; Vanderson Rocha; Carlo Dufour; Eliane Gluckman; Jakob Passweg; Annalisa Ruggeri
Journal:  Biol Blood Marrow Transplant       Date:  2017-08-07       Impact factor: 5.742

Review 7.  Transplantation for bone marrow failure: current issues.

Authors:  Régis Peffault de Latour
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood.

Authors:  H Mayani; P M Lansdorp
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

9.  Unrelated cord blood transplantation for severe aplastic anemia.

Authors:  Ayami Yoshimi; Seiji Kojima; Shuichi Taniguchi; Junichi Hara; Toshimitsu Matsui; Yoshiyuki Takahashi; Hiroshi Azuma; Koji Kato; Tokiko Nagamura-Inoue; Shunro Kai; Shunichi Kato
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

Review 10.  Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sarah Morin-Zorman; Pascale Loiseau; Jean-Luc Taupin; Sophie Caillat-Zucman
Journal:  Front Immunol       Date:  2016-08-12       Impact factor: 7.561
View more
  1 in total

1.  Antioxidant Small Molecule Compound Chrysin Promotes the Self-Renewal of Hematopoietic Stem Cells.

Authors:  Yinghui Li; Mei He; Wenshan Zhang; Ming Yang; Yahui Ding; Shiqi Xu; Jiali Gu; Yafang Li; Jingjing Yin; Yingdai Gao
Journal:  Front Pharmacol       Date:  2020-04-02       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.